High dose chemotherapy (HDC) with peripheral blood stem cell (PBSC) transplantation for patients (pts) with advanced ovarian cancer.

被引：0
|
作者：
Bojko, P
Hilger, R
Schenlen, ME
Oberhoff, C
Schindler, AE
Seeber, S
机构：
[1] Univ Essen Gesamthsch, W German Canc Ctr, Dept Internal Med, Essen, Germany
[2] Univ Essen Gesamthsch, Dept Obstet & Gynaecol, Essen, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
365P
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy (HDC), and peripheral blood stem-cell transplantation (PBSCT) is feasible in elderly (>age 60) patients (pts) with multiple myeloma (MM).
    Abou-Alfa, GK
    Nabbout, NN
    Seropian, S
    Medoff, E
    Cooper, DL
    ANNALS OF ONCOLOGY, 2000, 11 : 97 - 97
  • [22] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in locally advanced breast cancer. Updated results of a single center
    Kuzhan, O.
    Ozet, A.
    Arpaci, F.
    Komurcu, S.
    Ulutin, C.
    Ozturk, B.
    Ataergin, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 127 - 127
  • [23] High-dose chemotherapy of ovarian cancer followed by bone marrow transplantation or peripheral blood stem cell support
    Wcislo, Gabriel
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (01): : 14 - 22
  • [24] High-dose chemotherapy (HDC) and peripheral blood stem cell transplantation (PBSCT) prolongs survival in previously untreated patients with advanced stage multiple myeloma (MM).
    Nowrousian, MR
    Wrzeciono, T
    Welt, A
    Schutt, P
    Brandhorst, D
    Ebeling, P
    Kloke, O
    Moritz, T
    Flasshove, M
    Schutte, J
    Seeber, S
    BLOOD, 2002, 100 (11) : 474B - 474B
  • [25] Early infectious complications after high-dose chemotherapy (HDC) with peripheral blood stem cell transplantation (PBSCT) in breast cancer (BC).
    Irrera, G
    Messina, G
    Iacopino, O
    Pucci, G
    Martino, M
    Cuzzola, M
    Console, G
    Pontari, A
    Morabito, F
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 1999, 23 : S116 - S116
  • [26] Phase III randomized trial of high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) support as consolidation in patients (pts) with advanced ovarian cancer (AOC): 5-year follow-up of a GINECO/FNCLCC/SFGM-TC study.
    Cure, H
    Battista, C
    Guastalla, JP
    Fabbro, M
    Tubiana, N
    Bourgeois, H
    Lioure, B
    Chiurazzi, B
    Paraiso, D
    Pujade-Lauraine, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 450S - 450S
  • [27] High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
    Schmid, M
    Bauernhofer, T
    Resel, M
    Ploner, F
    Schippinger, W
    Gilli, R
    Lanzer, G
    Truschnig-Wilders, M
    Samonigg, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S42 - S42
  • [28] Neoadjuvant intraarterial high-dose chemotherapy and autologous peripheral blood stem cell transplantation for advanced breast cancer
    Yagihashi, A
    Okazaki, M
    Hirata, K
    Ohmura, T
    Okazaki, A
    Suzuki, Y
    Yuyama, Y
    Okamoto, J
    Wada, Y
    Yajima, T
    Kameshima, H
    Araya, J
    Yanai, Y
    Endoh, T
    Watanabe, N
    ONCOLOGY REPORTS, 1999, 6 (06) : 1299 - 1302
  • [29] Analysis of pulmonary infections during high-dose chemotherapy (HDC) and peripheral blood stem cell autologous transplantation (PBSCT)
    Sola, C
    Salazar, R
    Maroto, P
    Tabernero, JM
    Valenti, V
    Brunet, J
    Ojeda, B
    Alonso, MC
    Verger, G
    Lopez, JJL
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 421 - 421
  • [30] High-dose chemotherapy with peripheral blood stem cell transplantation in breast cancer management
    Jentsch-Ullrich, K
    Höffken, HG
    Franke, A
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 162 - 164
12345